Skip to content Accessibility statement

Global Health Seminar: Decision-analytic model for Human T-lymphotropic virus 1 (HTLV-1) antenatal screening in the UK

Seminar

This event has now finished.

Event date
Tuesday 5 May 2026, 2.10pm to 3pm
Location
A/A/019/020, Alcuin A Block, University of York, Zoom link available via the mailing list - joining details below (not recorded)
Audience
Open to staff, students (postgraduate researchers only)
Admission
Free admission, booking not required

Event details

Abstract

HTLV-1 is a lifelong retroviral infection transmitted via bodily fluids, including breastfeeding. It can lead to severe late-onset disease, such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukaemia/lymphoma (ATLL). Although UK prevalence is low, targeted antenatal screening has been proposed for pregnant women at increased risk of infection to prevent mother-to-child transmission.

In this seminar, we present a systematic review of the association between HTLV-1 infection and adverse health outcomes, alongside an exploratory decision-analytic model evaluating the clinical impact, harms, and cost-effectiveness of targeted antenatal screening.

Fifteen cohort studies (29,335 participants) were included in the systematic review of health outcomes associated with HTLV-1 infection. No studies were conducted in the UK, with nearly all being undertaken in countries where the HTLV-1 virus is endemic. Most studies were of low or unclear methodological quality. A pairwise meta-analysis of individual effect estimates suggested an association between HTLV-1 infection and increased all-cause mortality (pooled effect estimate from 7 studies 1.62, 95% CI 1.41 to 1.87, I2=0). Consistent evidence was lacking for cause-specific mortality and morbidity outcomes, precluding further meta-analysis.

The model estimated that targeted screening could prevent 41 infant infections annually. Over time, this would avert one case of HAM/TSP and three cases of ATLL. However, screening was associated with increased costs and small net losses in quality-adjusted life years (QALYs), primarily driven by the psychological impact of being aware of an incurable lifelong infection. However, even when this disutility was excluded, screening remained cost-ineffective.

 

If you are not a member of University of York staff and are interested in attending a seminar, please contact akseer.hussain@york.ac.uk so that you can be added to the mailing list.

Speakers: Susan O'Meara and Rob Hodgson, CRD University of York

Susan O'Meara's profile

Rob Hodgson's profile

Venue details

Wheelchair accessible

Contact

For information about Global Health seminars, please contact Akseer Hussain.

akseer.hussain@york.ac.uk